Lidoderm: all 46 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Lidocaine Patch for Epidural Placement Pain in Laboring WomenRecruitingNCT07700108Phase 3
• Lidocaine Patch and Lower Third MolarNot yet recruitingNCT07330726Phase 3
• Lidocaine Patches Prior to Percutaneous Nerve EvaluationCompletedNCT05783219Phase 2Results posted
• Lidocaine Patches in Elderly Patients With Traumatic Rib FracturesTerminatedNCT05714631Phase 4Results posted
• Pain Control for Breast Cancer Patients Receiving Injection of Radioactive TracerCompletedNCT04822597Phase 3Results posted
• Lidocaine Patches After Cesarean SectionCompletedNCT04443569Phase 3Results posted
• Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency DepartmentCompletedNCT03571737Phase 3Results posted
• Post-Op Lidocaine PatchCompletedNCT03500211Phase 4Results posted
• Pharmacokinetics of Lidocaine in Healthy AdultsCompletedNCT03310970Phase 4Results posted
• PK and DPK of Lidocaine Dermal ProductsCompletedNCT03145207Early Phase 1Results posted
• Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve SurgeryCompletedNCT03120351Not applicableResults posted
• Symptom Management After Breast Cancer SurgeryCompletedNCT00686127Phase 4Results posted
• Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the KneeCompletedNCT00589979Phase 2Results posted
• Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple SclerosisTerminatedNCT00414453Phase 4Results posted
• Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water ExposureCompletedNCT04784728Phase 1
• Transdermal Lidocaine for Pain Control During Diagnostic Office HysteroscopyStatus unknownNCT04518202Not applicable
• Transdermal Lidocaine for Pain Control During HysterosalpingographyStatus unknownNCT04518189Not applicable
• Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine SystemStatus unknownNCT04517890Not applicable
• Lidocaine Patch Versus Intravenous Lidocaine in Pain Relief After Cesarean SectionStatus unknownNCT04505644Not applicable
• Lidocaine Patch for Neck PainCompletedNCT04378959Not applicable
• Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human SubjectsCompletedNCT04320173Phase 1
• Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human SubjectsCompletedNCT04319926Phase 1
• Adhesion of Lidocaine Topical System 1.8%CompletedNCT04312750Phase 1
• Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and ExerciseCompletedNCT04150536Phase 1
• Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy SubjectsCompletedNCT04149938Phase 1
• Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy SubjectsCompletedNCT04144192Phase 1
• The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy AnalysisTerminatedNCT04033562Phase 4
• Localized Neuropathic Pain: Topical Treatment Versus Systemic TreatmentTerminatedNCT03348735Phase 4
• Effect of Lidocaine Patch for Shoulder Pain in Laparoscopic CholecystectomyCompletedNCT02827136Not applicable
• Topical Anesthesia for Removal of Stitches After Total Knee ArthroplastyStatus unknownNCT02812602Not applicable
• Preventive Skin Analgesia With Lidocaine Patch 5% for Controlling Post-thoracotomy PainCompletedNCT02751619Not applicable
• Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated PainCompletedNCT02452112Phase 2/3
• Evaluation of the Depth and Duration of Anesthesia From Heated Lidocaine/Tetracaine (Synera®) Patches Compared With 5% Lidocaine (Lidoderm®) Patches Applied to Healthy Adult VolunteersCompletedNCT01688518Phase 1
• Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy PainCompletedNCT01443325Phase 3
• Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring PatientsWithdrawnNCT01307839Not applicable
• Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the KneeTerminatedNCT00904605Phase 4
• Topical Lidocaine Patch in Low Back PainCompletedNCT00904540Phase 4
• Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back PainCompletedNCT00904475Phase 4
• Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the KneeCompletedNCT00904462Phase 2
• Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back PainTerminatedNCT00904397Phase 4
• A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain ConditionsCompletedNCT00904202Phase 4
• A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back PainCompletedNCT00904111Phase 2
• A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back PainCompletedNCT00904020Phase 4
• Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic NeuropathyCompletedNCT00903851Phase 4
• Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and HyperalgesiaCompletedNCT00373893Phase 1
• Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel SyndromeTerminatedNCT00266214Phase 3

← Lidoderm overview